title: Late paradoxical development of pyoderma gangrenosum in a psoriasis patient treated with infliximab.
authors: Section of Dermatology, Department of Biomedical Science and Human Oncology, University of Bari, 11, Piazza Giulio Cesare, Bari, 70124, Italy.
authors: Michelangelo
authors: M
authors: Vestita
authors: Section of Dermatology, Department of Biomedical Science and Human Oncology, University of Bari, 11, Piazza Giulio Cesare, Bari, 70124, Italy.
authors: Stefania
authors: S
authors: Guida
authors: Section of Dermatology, Department of Biomedical Science and Human Oncology, University of Bari, 11, Piazza Giulio Cesare, Bari, 70124, Italy.
authors: Stella
authors: S
authors: Mazzoccoli
authors: Section of Dermatology, Department of Biomedical Science and Human Oncology, University of Bari, 11, Piazza Giulio Cesare, Bari, 70124, Italy.
authors: Francesco
authors: F
authors: Loconsole
authors: Section of Dermatology, Department of Biomedical Science and Human Oncology, University of Bari, 11, Piazza Giulio Cesare, Bari, 70124, Italy.
authors: Caterina
authors: C
authors: Foti
mesh_terms: D000328:Adult; D003879:Dermatologic Agents / Q000009:adverse effects*; D006801:Humans; D000069285:Infliximab / Q000009:adverse effects*; D008297:Male; D011565:Psoriasis / Q000188:drug therapy*; D017511:Pyoderma Gangrenosum / Q000139:chemically induced*; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D003879:Dermatologic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab